Widely used antidepressant outperformed by 3 other drugs in major study of 30,000 people

Three antidepressants may work better than fluoxetine, widely known by the brand name Prozac, at helping people with depression get better and stay well over time, a new study suggests.The research, published in The Lancet Psychiatry, compared 20 antidepressants to determine how well they eased depression symptoms and helped prevent them from returning over time.Researchers analyzed 115 previous clinical trials involving more than 30,000 people, according to a news release from Radboud University Medical Center in the Netherlands.CERTAIN SLEEP HABITS COULD OFFER CLUES TO HIDDEN TYPE OF DEPRESSION, SCIENTISTS SAYThey found that escitalopram, sold under the brand name Lexapro; duloxetine, sold as Cymbalta; and agomelatine performed better over the long term than fluoxetine, which researchers used as the main comparison drug.Eli Lilly told Fox News Digital that it discontinued manufacturing Prozac in 2024.The company noted that fluoxetine remains available in many FDA-approved generic medicines and that neither the study nor the university’s news release specifically referred to Prozac or any Lilly product.A new study suggests three antidepressants may work better than fluoxetine at helping people recover from depression and stay well over time.

(iStock)The findings suggest that antidepressants can continue helping people after their symptoms improve, although some medications appeared to work better than others at keeping patients well.Paul van Haaren, a researcher at Radboud University Medical Center who worked on the study, noted that the three medications have different benefits and drawbacks.CLICK HERE FOR MORE HEALTH STORIES"Escitalopram is already widely used," he said in the release."Agomelatine works well, but one of its side effects is the risk of liver failure.

Duloxetine is less well-known and is prescribed less frequently as a first-line treatment."Escitalopram belongs to a common group of antidepressants known as selective serotonin reuptake inhibitor...

Read More 
PaprClips
Disclaimer: This story is auto-aggregated by a computer program and has not been created or edited by PaprClips.
Publisher: Fox News

Recent Articles